Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors.
Serum factors that inhibit the binding of (125)I-labeled alpha-bungarotoxin to the acetylcholine receptor extracted in detergent from denervated rat muscle were detected by a sensitive assay. The serum of at least 5 and possibly 11 out of 15 patients with myasthenia gravis showed inhibitory activity that was localized to the globulin fraction. No controls showed inhibitory activity. The demonstration of inhibitory globulins may help explain the involvement of the immune system in the pathophysiology of the neuromuscular junction in patients with myasthenia gravis.
D000109:Acetylcholine / Q000378:metabolism; D000328:Adult; D000368:Aged; D000818:Animals; D001665:Binding Sites / Q000187:drug effects; D001667:Binding, Competitive; D002038:Bungarotoxins / Q000378:metabolism* / Q000494:pharmacology; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000097:blood* / Q000276:immunology / Q000378:metabolism / Q000503:physiopathology; D009469:Neuromuscular Junction / Q000276:immunology / Q000378:metabolism* / Q000503:physiopathology; D051381:Rats; D011950:Receptors, Cholinergic / Q000187:drug effects*; D012712:Serum Globulins / Q000378:metabolism*
D002038:Bungarotoxins; D007457:Iodine Radioisotopes; D011950:Receptors, Cholinergic; D012712:Serum Globulins; D000109:Acetylcholine